Improvement of treatment of primary adrenal insufficiency by administration of cortisone acetate in three daily doses
- PMID: 15008243
- DOI: 10.1007/BF03345252
Improvement of treatment of primary adrenal insufficiency by administration of cortisone acetate in three daily doses
Abstract
In the present study, we compared the effects of 3 daily administrations of cortisone acetate vs a classical regimen with 2 daily administrations, in patients with primary adrenal insufficiency (PAI). We enrolled 34 patients with PAI treated with 2 daily doses of cortisone acetate (2/3 of the total daily dose early in the morning, 1/3 in the afternoon) who were subdivided into two groups: group A (no. = 18; 4 males, 14 females; age: median 55 yr, range 24-88) continued with the standard 2 daily administrations, group B (no. = 16; 8 males, 8 females; age: median 44 yr, range 27-70) switched to 3 daily administrations (3/6 of the daily dose early in the morning, 2/6 after lunch, 1/6 after dinner), but without any change of the total daily dose. After 6 months of therapy, basal and 90-min post-cortisone acetate ACTH levels in group B (219 pg/ml, range 19.9-1197, and 84 pg/ml, range 14.4-480, respectively) were significantly lower than those observed at the beginning of the study (482 pg/ml, range 58-1900 and 215 pg/ml, range 52-1832, respectively; p = 0.001 and p = 0.027, respectively). No statistically significant differences were observed in group A. Similarly, 24-h urinary cortisol (UFC) excretion increased significantly after 6 months of a 3-dose therapy in group B (from 74.6 microg/24 h, range 24-148, to 98.8 microg/24 h, range 48-214; p = 0.006), but not in group A (p = ns). Moreover, UFC excretion after 6 months of a 3-dose therapy was significantly higher than after 6 months of a 2-dose therapy (98.8 microg/24 h, range 48-214 vs 49.8 microg/24 h, range 11-183, p = 0.032). No significant variations of basal and 90-min post-cortisone levels of cortisol were observed in either group. Our study demonstrates that the subdivision of the total daily dose of cortisone acetate in 3 administrations increases total UFC excretion and reduces plasma ACTH levels, thus improving the substitutive therapy.
Similar articles
-
Comparison of different regimens of glucocorticoid replacement therapy in patients with hypoadrenalism.J Endocrinol Invest. 2005 Jul-Aug;28(7):632-7. doi: 10.1007/BF03347262. J Endocrinol Invest. 2005. PMID: 16218046
-
Dose distribution in hydrocortisone replacement therapy has a significant influence on urine free cortisol excretion.Exp Clin Endocrinol Diabetes. 2003 Oct;111(7):443-6. doi: 10.1055/s-2003-44292. Exp Clin Endocrinol Diabetes. 2003. PMID: 14614652
-
Non-physiological levels of circulating cortisol in growth hormone-treated hypopituitary adults after conventional cortisone substitution.Scand J Clin Lab Invest. 2004 Apr;64(2):132-9. doi: 10.1080/00365510410004867. Scand J Clin Lab Invest. 2004. PMID: 15115251 Clinical Trial.
-
Isolated corticotrophin deficiency.Pituitary. 2006;9(4):289-95. doi: 10.1007/s11102-006-0408-5. Pituitary. 2006. PMID: 17077949 Review.
-
Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors.Expert Opin Drug Metab Toxicol. 2008 Jun;4(6):749-58. doi: 10.1517/17425255.4.6.749. Expert Opin Drug Metab Toxicol. 2008. PMID: 18611115 Review.
Cited by
-
Switching From Immediate-Release to Fractionated Dual-Release Hydrocortisone May Improve Metabolic Control and QoL in Selected Primary Adrenal Insufficiency Patients.Front Endocrinol (Lausanne). 2021 Feb 1;11:610904. doi: 10.3389/fendo.2020.610904. eCollection 2020. Front Endocrinol (Lausanne). 2021. PMID: 33597926 Free PMC article.
-
Therapy of adrenal insufficiency: an update.Endocrine. 2013 Jun;43(3):514-28. doi: 10.1007/s12020-012-9835-4. Epub 2012 Nov 21. Endocrine. 2013. PMID: 23179775 Review.
-
Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline.J Clin Endocrinol Metab. 2016 Feb;101(2):364-89. doi: 10.1210/jc.2015-1710. Epub 2016 Jan 13. J Clin Endocrinol Metab. 2016. PMID: 26760044 Free PMC article. Review.
-
Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion.J Endocrinol Invest. 2020 May;43(5):683-696. doi: 10.1007/s40618-019-01146-y. Epub 2019 Nov 26. J Endocrinol Invest. 2020. PMID: 31773582
-
Recurrent nocturnal hypoglycaemia as a cause of morning fatigue in treated Addison's disease--favourable response to dietary management: a case report.BMC Endocr Disord. 2015 Oct 24;15:61. doi: 10.1186/s12902-015-0058-6. BMC Endocr Disord. 2015. PMID: 26500000 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous